Study on correlations of BDNF, PI3K, AKT and CREB levels with depressive emotion and impulsive behaviors in drug-naïve patients with first-episode schizophrenia

[1]  Hala F Zaki,et al.  Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats , 2022, Inflammopharmacology.

[2]  P. Jia,et al.  Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery , 2022, European Neuropsychopharmacology.

[3]  M. Bai,et al.  Predictive effect of Bayes discrimination in the level of serum protein factors and cognitive dysfunction in schizophrenia. , 2022, Journal of psychiatric research.

[4]  Keqiang Gao,et al.  Modafinil rescues repeated morphine‐induced synaptic and behavioural impairments via activation of D1R–ERK–CREB pathway in medial prefrontal cortex , 2021, Addiction biology.

[5]  Hailou Zhang,et al.  Quercitrin Rapidly Alleviated Depression-like Behaviors in Lipopolysaccharide-Treated Mice: The Involvement of PI3K/AKT/NF-κB Signaling Suppression and CREB/BDNF Signaling Restoration in the Hippocampus. , 2021, ACS chemical neuroscience.

[6]  M. Xiu,et al.  Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up , 2021, Psychoneuroendocrinology.

[7]  A. Szulc,et al.  Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD) , 2021, Journal of clinical medicine.

[8]  Xiangyang Zhang,et al.  Association of depressive symptoms with cognitive impairment in patients with never-treated first-episode schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study. , 2021, General hospital psychiatry.

[9]  V. Carli,et al.  Suicide prevention in psychiatric patients , 2021, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

[10]  D. Manickam,et al.  Targeting the blood-brain barrier for the delivery of stroke therapies. , 2021, Advanced drug delivery reviews.

[11]  Huanzhong Liu,et al.  Insomnia, suicidal ideation, and psychopathology in Chinese patients with chronic schizophrenia , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  Feng Yang,et al.  PKBβ/AKT2 deficiency impacts brain mTOR signaling, prefrontal cortical physiology, hippocampal plasticity and select murine behaviors , 2020, Molecular Psychiatry.

[13]  Zhongming Zhao,et al.  Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients , 2020, Neuropsychopharmacology.

[14]  S. Grover,et al.  Depression in schizophrenia: Prevalence and its impact on quality of life, disability, and functioning. , 2020, Asian journal of psychiatry.

[15]  F. Kapczinski,et al.  Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population , 2020, Diagnostics.

[16]  Xiufeng Xu,et al.  Different serum protein factor levels in first‐episode drug‐naive patients with schizophrenia characterized by positive and negative symptoms , 2020, Psychiatry and clinical neurosciences.

[17]  S. Potkin,et al.  Effect of brexpiprazole on control of impulsivity in schizophrenia: A randomized functional magnetic resonance imaging study , 2020, Psychiatry Research: Neuroimaging.

[18]  Jian-Zhi Wang,et al.  ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia , 2020, Neurotherapeutics.

[19]  B. Ho,et al.  Impulsive decision making, brain cortical thickness and familial schizophrenia risk , 2020, Schizophrenia Research.

[20]  J. Meador-Woodruff,et al.  Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia , 2020, Neuropsychopharmacology.

[21]  C. Carter,et al.  Delay discounting abnormalities are seen in first-episode schizophrenia but not in bipolar disorder , 2020, Schizophrenia Research.

[22]  Chen Zhang,et al.  Depressive symptoms in schizophrenia patients: A possible relationship between SIRT1 and BDNF , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  Chen Zhang,et al.  Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia , 2019, Psychiatry Research.

[24]  N. Hoertel,et al.  Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study. , 2019, Journal of affective disorders.

[25]  Y. Kitagishi,et al.  Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses , 2019, Diseases.

[26]  O. Wiborg,et al.  BDNF+/− rats exhibit depressive phenotype and altered expression of genes relevant in mood disorders , 2018, Genes, brain, and behavior.

[27]  P. Sarret,et al.  The 5α-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia , 2018, Physiology & Behavior.

[28]  B. Zhong,et al.  Depressive symptoms in Chinese male inpatients with schizophrenia: Prevalence and clinical correlates , 2018, Psychiatry Research.

[29]  Zhenzhong Wang,et al.  Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling , 2018, Acta Pharmacologica Sinica.

[30]  Chen Zhang,et al.  Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study , 2018, Psychopharmacology.

[31]  A. Mohammadi,et al.  Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases. , 2018, Current gene therapy.

[32]  C. Lançon,et al.  High C-reactive protein levels are associated with depressive symptoms in schizophrenia. , 2018, Journal of affective disorders.

[33]  Chen Zhang,et al.  Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha , 2017, Psychoneuroendocrinology.

[34]  A. Law,et al.  PKBγ/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia , 2017, PloS one.

[35]  Peng Yan,et al.  The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration , 2017, The international journal of neuropsychopharmacology.

[36]  J. Ma,et al.  Neuroprotective action of N-acetyl serotonin in oxidative stress-induced apoptosis through the activation of both TrkB/CREB/BDNF pathway and Akt/Nrf2/Antioxidant enzyme in neuronal cells , 2017, Redox biology.

[37]  M. Birchwood,et al.  Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue? , 2016, Schizophrenia bulletin.

[38]  Guofu Zhang,et al.  The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients , 2016, Psychiatry Research.

[39]  D. Bennett,et al.  Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells , 2016, Molecular Psychiatry.

[40]  Y. Fang,et al.  Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers , 2016, Scientific Reports.

[41]  Rocío B Foltran,et al.  BDNF isoforms: a round trip ticket between neurogenesis and serotonin? , 2016, Journal of neurochemistry.

[42]  L. Aurelian,et al.  TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation , 2016, Translational psychiatry.

[43]  H. Larsson,et al.  Genetic and environmental determinants of violence risk in psychotic disorders: a multivariate quantitative genetic study of 1.8 million Swedish twins and siblings , 2015, Molecular Psychiatry.

[44]  C. Cohen,et al.  A Longitudinal Study of the Outcome and Associated Factors of Subsyndromal and Syndromal Depression in Community-Dwelling Older Adults with Schizophrenia Spectrum Disorder. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[45]  Matthew J Hoptman,et al.  Impulsivity and aggression in schizophrenia: a neural circuitry perspective with implications for treatment , 2015, CNS Spectrums.

[46]  M. Berk,et al.  Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications , 2014, Molecular Psychiatry.

[47]  J. Cadet,et al.  Transcriptional and Epigenetic Substrates of Methamphetamine Addiction and Withdrawal: Evidence from a Long-Access Self-Administration Model in the Rat , 2014, Molecular Neurobiology.

[48]  Z. Fišar,et al.  GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[49]  J. Ai,et al.  MicroRNA-195 Protects Against Dementia Induced by Chronic Brain Hypoperfusion via Its Anti-Amyloidogenic Effect in Rats , 2013, The Journal of Neuroscience.

[50]  A. Pillai,et al.  BDNF-TrkB signaling and neuroprotection in schizophrenia. , 2013, Asian journal of psychiatry.

[51]  E. Sibille,et al.  Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. , 2012, The American journal of psychiatry.

[52]  K. Hsu,et al.  Prenatal stress alters hippocampal synaptic plasticity in young rat offspring through preventing the proteolytic conversion of pro‐brain‐derived neurotrophic factor (BDNF) to mature BDNF , 2012, The Journal of physiology.

[53]  J. Beaulieu.  A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. , 2012, Journal of psychiatry & neuroscience : JPN.

[54]  E. Sinforiani,et al.  Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease , 2011, Neurobiology of Aging.

[55]  S. Itohara,et al.  Matrix Metalloproteinase-9 Contributes to Kindled Seizure Development in Pentylenetetrazole-Treated Mice by Converting Pro-BDNF to Mature BDNF in the Hippocampus , 2011, The Journal of Neuroscience.

[56]  T. Kosten,et al.  Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes , 2009, Psychopharmacology.

[57]  Hongyan Zhang,et al.  Reliability and Validity of the Chinese Version of the Calgary Depression Scale for Schizophrenia , 2009, The Australian and New Zealand journal of psychiatry.

[58]  Petti T. Pang,et al.  The yin and yang of neurotrophin action , 2005, Nature Reviews Neuroscience.

[59]  M. Chao,et al.  Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.

[60]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[61]  E. Castrén,et al.  Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. , 2002, Biochemical and biophysical research communications.

[62]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[63]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[64]  H. Häfner,et al.  Epidemiology of Schizophrenia , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.